Bisphosphonates in osteoporosis: NICE and easy? - Wikidata - wikimedia - TriplyDB

Bisphosphonates in osteoporosis: NICE and easy?

Bisphosphonates in osteoporosis: NICE and easy?

http://www.wikidata.org/entity/Q49816150

about

Implications of guidelines for osteoporosis and its treatment.

P2860

Q47177624-F00F9385-F0ED-4D5B-B399-02D7A9CB25DF

P2860

Bisphosphonates in osteoporosis: NICE and easy?

http://www.wikidata.org/entity/Q49816150

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Bisphosphonates in osteoporosis: NICE and easy?

@en

Bisphosphonates in osteoporosis: NICE and easy?

@nl

type

label

Bisphosphonates in osteoporosis: NICE and easy?

@en

Bisphosphonates in osteoporosis: NICE and easy?

@nl

prefLabel

Bisphosphonates in osteoporosis: NICE and easy?

@en

Bisphosphonates in osteoporosis: NICE and easy?

@nl

P1433

Q49816150-DD1C112C-55CE-4269-82BC-03886808165A

P1476

Q49816150-2C4CCAA7-BEFE-436A-A7CC-375B9B590C34

P2093

Q49816150-28B25267-10D5-4028-BE06-B9ADEE2AFB7B

Q49816150-3D96B771-ACF8-4F74-8C2D-F8678703AD82

Q49816150-D2A198CA-418E-400E-B4E1-116C3EDB3730

P2860

Q49816150-2133913D-C935-409D-BE8E-4924C84E3942

Q49816150-83A5A805-F179-4895-9152-9A7EAA131FE7

Q49816150-9B354E16-76BC-41EC-B096-4AAC006B27F4

Q49816150-CA0BA30C-3FDA-4FFB-8C2A-5A3C65DCD85E

Q49816150-CD5718F0-8055-4A1D-A5B5-7EA842153F84

Q49816150-D7330EFC-C5B1-4FE2-B01F-6F329D99E6CF

Q49816150-E3AD78B3-2BA3-4212-9AF8-C819C6D36A83

P304

Q49816150-C43B3A7B-8050-4A2A-88AC-5663411F04A5

P31

Q49816150-00F34922-CA42-48DB-A8AC-46CCFFE25C6A

P356

Q49816150-D4A3A827-56D4-43E0-A8C2-B284FF967113

P407

Q49816150-A942A79A-A847-4D3C-BEF0-7131FB959703

P433

Q49816150-F1A60042-8C34-4C12-9B88-7D6B79AD2E7A

P478

Q49816150-4A5B42B9-F29C-4E24-8197-C722C2B658D7

P50

Q49816150-1C1B290C-6905-4BEE-9811-BC5DFC75EB93

Q49816150-64A1DAEC-BD17-4230-8126-5919AECB49C3

P577

Q49816150-90ADB3AB-4831-41D2-9E82-564F6B3026A8

P698

Q49816150-72C114AF-6648-40B1-9E87-1792E69C1DC6

P921

Q49816150-1309B419-2ECA-4E8B-B812-A2DCEA4FBEB4

P932

Q49816150-A46F941F-A7C6-42CD-BF52-8B07B414433D

P356

S0140-6736(17)32850-7

P1433

P1476

Bisphosphonates in osteoporosis: NICE and easy?

@en

P2093

Eugene McCloskey

http://www.w3.org/2001/XMLSchema#string

John A Kanis

http://www.w3.org/2001/XMLSchema#string

Juliet Compston

http://www.w3.org/2001/XMLSchema#string

P2860

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

UK clinical guideline for the prevention and treatment of osteoporosis

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

The cost-effectiveness of alendronate in the management of osteoporosis.

Clinical assessment and management of multimorbidity: summary of NICE guidance.

P304

2243-2244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(17)32850-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

10109

http://www.w3.org/2001/XMLSchema#string

P478

390

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas C Harvey

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29165263

http://www.w3.org/2001/XMLSchema#string

P921

P932

5724749

http://www.w3.org/2001/XMLSchema#string